RFDA
+2.97 · +4.85%
$64.21 · NYSE ARCA

RiverFront Dynamic US Dividend Advantage ETF (RFDA) ETF Analysis | Large Value

ALPS · United States
AUM:$83.2M
#– of – in Large Value ETFs

Educational tool only – Figures are based on historical data, holdings and expense metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Market Performance

Up 17.1% over the past year, showing positive momentum.

Cost Efficiency

Ongoing charge of 0.52% — moderate cost. Consider how fees compound over long holding periods.

What is RFDA?

The fund invests at least 65% of its net assets in a portfolio of equity securities of publicly traded U. companies with the potential for dividend income.

Performance Highlights

Returns (%)
Top Sectors (%)

Investment Breakdown

Strong Recent Performance
RFDA delivered 17.1% over the past year. Historical returns only — past performance is not indicative of future results.
Moderate Cost
Expense ratio of 0.52%. Consider how fees compound over a long holding period.
Moderate Concentration
Top 10 holdings make up 45.0% of the ETF — a moderate level of name concentration.
ETF Information
AUM$83.2M
Expense Ratio0.52%
Dividend Yield1.79%
Holdings49
Inception DateJun 2016
DomicileUnited States
DistributionNA
Index–
ProviderALPS
Beta0.96
CategoryLarge Value
CurrencyUSD
Portfolio Impact

How would RFDA affect your portfolio?

Sign in to see exactly what adding this ETF changes — sector exposure, yield, diversification, volatility. Real numbers from your actual holdings.

Sign in
Example preview
6168
+7 points · better diversified

Chart Tools

Sign in to overlay your portfolio on the chart.

Sign in
Uses ISF.L (iShares FTSE 100 ETF)
Indicators

Performance Metrics

Historical returns

6M
+15.7%
1Y
+21.1%
3Y
+71.0%
5Y
+83.3%
OpenBook InsightIf you had invested £10,000 in RFDA 5 years ago, it would have grown to £18,328 — a gain of £8,328.

Annual Returns

Calendar year performance

RFDA delivered positive returns in 4 of the last 5 calendar years.
YearRFDA
2026 YTD+16.6%
2025+16.5%
2024+20.0%
2023+17.3%
2022-9.2%
CAGR 4yr+10.5%
4/5 positive yearsAvg return: +12.2%Worst year: -9.2% (2022)

Technical Analysis Summary

Automated insights from historical price action and indicators

Technical Regime: POSITIVE
Trend Strength
100%
Positive
Volatility
8.5%
Low
Momentum
+4.1%
30-day change
Support Level
72.48
Key floor
Key Insights
  • Price is currently trading above all key moving averages.
  • Low volatility environment with a narrower recent trading range.
  • Monitor key support and resistance levels as part of broader risk assessment.